僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Camidanlumab （HuMax-TAC） is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates （ADCs） to research several diseases including lymphoma and leukemia